Home » Topics » BioWorld Science

BioWorld Science
RSS

Dompe Farmaceutici describes new peptides with angiogenic activity

March 28, 2022

HDAC inhibitors disovered at Chong Kun Dang Pharmaceutical

March 28, 2022

Yale University divulges new oligosaccharyltransferase complex inhibitors

March 28, 2022

New antibacterials identified at Roche

March 28, 2022

Phosphatidylserine is crucial for synaptic pruning in adult-born neurons

March 28, 2022

Novel nonhallucinogenic DMT analogues as drug candidates for mental health and addiction disorders

March 28, 2022

MK-6158: sGC stimulator clinical candidate for pulmonary arterial hypertension

March 28, 2022

Variant in the CTR1 gene causes novel disorder of copper metabolism

March 28, 2022

Identification of sites of metabolic liability for KRM-II-81 and evaluation of a deuterated analogue

March 28, 2022

Predictive Oncology validates Discovery 21 results

March 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...